Nicotinamide potentiates amphotericin B activity against Candida albicans

References

• Sardi JC, Scorzoni L, Bernardi T, et al. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol. 2013;62(1):10–24. DOI:10.1099/jmm.0.045054-0.
   PubMedGoogle Scholar
• Oura M, Sternberg TH, Wright ET. A new antifungal antibiotic, amphotericin B. Antibiot Annu. 1955;3:566–573.
   PubMedGoogle Scholar
• Laniado-Laborín R, Cabrales-Vargas MN. Amphotericin B: side effects and toxicity. Rev Iberoam de Micología. 2009;26(4):223–227.
   PubMed Web of Science ®Google Scholar
• Chen AC, Martin AJ, Choy B, et al. A phase 3 randomized trial of nicotinamide for skin cancer chemoprevention. N Engl J Med. 2015;373(17):1618–1626. DOI:10.1056/NEJMoa1506197.
   PubMed Web of Science ®Google Scholar
• Murray MF. Nicotinamide: an oral antimicrobial agent with activity against both Mycobacterium tuberculosis and human immunodeficiency virus. Clin Infect Dis. 2003;36(4):453–460.
   PubMed Web of Science ®Google Scholar
• Sereno D, Alegre AM, Silvestre R, et al. In vitro antileishmanial activity of nicotinamide. Antimicrob Agents Chemother. 2005;49(2):808–812. DOI:10.1128/AAC.49.2.808-812.2005.
   PubMed Web of Science ®Google Scholar
• Gazanion E, Vergnes B, Seveno M, et al. In vitro activity of nicotinamide/antil- eishmanial drug combinations. Parasitol Int. 2011;60(1):19–24. DOI:10.1016/j.parint.2010.09.005.
   PubMed Web of Science ®Google Scholar
• Prusty D, Mehra P, Srivastava S, et al. Nicotinamide inhibits Plasmodium falciparum Sir2 activity in vitro and parasite growth. FEMS Microbiol Lett. 2008;282(2):266–272. DOI:10.1111/j.1574-6968.2008.01135.x.
   PubMed Web of Science ®Google Scholar
• Soares MB, Silva CV, Bastos TM, et al. Anti-Trypanosoma cruzi activity of nicotinamide. Acta Trop. 2012;122(2):224–229. DOI:10.1016/j.actatropica.2012.01.001.
   PubMed Web of Science ®Google Scholar
• Xing XR, Liao ZB, Tan F, et al. Effect of nicotinamide against Candida albicans. Front Microbiol. 2019;10:595.
   PubMed Web of Science ®Google Scholar
• Wurtele H, Tsao S, Lepine G, et al. Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy. Nat Med. 2010;16(7):774–780. DOI:10.1038/nm.2175.
   PubMed Web of Science ®Google Scholar
• Quan H, Cao YY, Xu Z, et al. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole. Antimicrob Agents Chemother. 2006;50(3):1096–1099. DOI:10.1128/AAC.50.3.1096-1099.2006.
   PubMed Web of Science ®Google Scholar
• Ramage G, Vande Walle K, Wickes BL, et al. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother. 2001;45(9):2475–2479. DOI:10.1128/AAC.45.9.2475-2479.2001.
   PubMed Web of Science ®Google Scholar
• Nobile CJ, Andes DR, Nett JE, et al. Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog. 2006;2(7):e63. DOI:10.1371/journal.ppat.0020063.
   PubMed Web of Science ®Google Scholar
• Li DD, Chai D, Huang XW, et al. Potent in vitro synergism of fluconazole and osthole against fluconazole-resistant Candida albicans. Antimicrob Agents Chemother. 2017;61(8):e00436–17. DOI:10.1128/AAC.00436-17.
   PubMed Web of Science ®Google Scholar
• Yan Y, Tan F, Miao H, et al. Effect of shikonin against Candida albicans biofilms. Front Microbiol. 2019;10:1085.
   PubMed Web of Science ®Google Scholar
• Liao ZB, Zhu ZY, Li L, et al. Metabonomics on Candida albicans indicate the excessive H3K56ac is involved in the antifungal activity of Shikonin. Emerg Microbes Infect. 2019;8(1):1243–1253. DOI:10.1080/22221751.2019.1657362.
   PubMed Web of Science ®Google Scholar
• Celic I, Masumoto H, Griffith WP, et al. The sirtuins hst3 and Hst4p preserve genome integrity by controlling histone h3 lysine 56 deacetylation. Curr Biol. 2006;16(13):1280. DOI:10.1016/j.cub.2006.06.023.
   PubMed Web of Science ®Google Scholar
• Mei Y, Jiang T, Zou Y, et al. FDA approved drug library screening identifies robenidine as a repositionable antifungal. Front Microbiol. 2020;11:996.
   PubMed Web of Science ®Google Scholar
• Sokol-Anderson MJE, Sligh JS, Elberg J, et al. Role of cell defense against oxidative damage in the resistance of Candida albicans to the killing effect of amphotericin B. Antimicrob Agents Chemother. 1988;32(5):702–705. DOI:10.1128/AAC.32.5.702.
   PubMed Web of Science ®Google Scholar
• Sokol-Anderson ML, Brajtburg J, Medoff G. Amphotericin B-induced oxidative damage and killing of C. albicans. J Infect Dis. 1986;154(1):76–83.
   PubMed Web of Science ®Google Scholar
• Fernández-García R, Muñoz-García JC, Wallace M, et al. Self-Assembling, supramolecular chemistry and pharmacology of amphotericin B: poly-aggregates, oligomers and monomers. J Control Release. 2022;341:716–732.
   PubMed Web of Science ®Google Scholar
• Moye-Rowley W. Regulation of the transcriptional response to oxidative stress in fungi: similarities and differences. Eukaryot Cell. 2003;2(3):381–389.
   PubMedGoogle Scholar
• Wang Y, Cao Y, Jia X, et al. Cap1p is involved in multiple pathways of oxidative stress response in Candida albicans. Free Rad Biol Med. 2006;40(7):1201–1209. DOI:10.1016/j.freeradbiomed.2005.11.019.
   PubMed Web of Science ®Google Scholar
• Hwang CS, Baek YU, Yim HS, et al. Protective roles of mitochondrial manganese-containing superoxide dismutase against various stresses inCandida albicans. Yeast. 2003;20(11):929–941. DOI:10.1002/yea.1004.
   PubMed Web of Science ®Google Scholar
• Marmorstein R, Zhou M. Writers and readers of histone acetylation: structure, mechanism, and inhibition. Cold Spring Harb Perspect Biol. 2014;6(7):a018762.
   PubMed Web of Science ®Google Scholar
• Sellam A, Askew C, Epp E, et al. Genome-Wide mapping of the coactivator Ada2p yields insight into the functional roles of SAGA/ADA complex in Candida albicans. Mol Biol Cell. 2009;20(9):2389–2400. DOI:10.1091/mbc.e08-11-1093.
   PubMed Web of Science ®Google Scholar
• Dahlin JL, Chen X, Walters MA, et al. Histone modifying enzymes, histone modifications and histone chaperones in nucleosome assembly: lessons learned from Rtt109 histone acetyltransferases. Crit Rev Biochem Mol Biol. 2015;50:31–53.
   PubMed Web of Science ®Google Scholar
• da Rosa L, Boyartchuk VL, Zhu LJ, et al. Histone acetyltransferase Rtt109 is required for Candida albicans pathogenesis. Proc Natl Acad Sci USA. 2010;107(4):1594–1599. DOI:10.1073/pnas.0912427107.
   PubMed Web of Science ®Google Scholar